Skip to main content
Caplight Logo









Proteinea

Proteinea

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.proteinea.com/

Last Round

Seed

Mar 14, 2022

Total Funding Raised

$4.75M

Company Overview

Proteinea is a biotechnology company that provides an AI-driven protein engineering platform for antibody-based therapeutic discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

protein engineeringantibody engineeringAI for drug discoveryProtein Language ModelPLMfoundation modelgenerative biologyprotein designAnkhfrontier AI labbiotherapeuticsdrug development partnershipswet-lab validationcomputational biologyself-driving labFc domain engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proteinea Comparables

Compare Proteinea with similar companies based on industry and business-model similarity.

Proteinea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AI Proteins
89%
EvolutionaryScale
86%
BigHat Biosciences
84%

Proteinea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 14, 2022
AcceleratorMar 17, 2021
AcceleratorFeb 16, 2020

Key People

Founding team and executive leadership

Abdulaziz Elgammal

Co-founder & CPO

Founding Team

Mahmoud Eljendy

Co-Founder & CEO

Founding Team

Proteinea Investors

Notable investors and investment history

Proteinea investors
InvestorRounds
Shorooq PartnersSeed
Flat6LabsAccelerator
500 GlobalSeed
Sawari VenturesSeed
Sadu CapitalSeed
VentureSouqSeed
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2024

    Monthly visitors increased 1068% MoM, reaching 2.5K.

  • Oct 29, 2024

    Monthly visitors increased 146% MoM.

Proteinea Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Proteinea Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proteinea's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range51
Year Founded2019
Last FundingMar 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?